MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-17-0020251
Allegiant Pharma Private Limited
Allegiant Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹47.05 Lakh
▲ 48% YoY
Net profit · FY 2024
₹11,690
Net margin 0.2%
EBITDA · FY 2024
₹90,565
EBITDA margin 1.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Allegiant Pharma Private Limited
Data last updated:
Allegiant Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC291235. Its GSTIN is 27AAPCA2441P1Z7 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Kumar Dubey and Rani Devi Ajay Dubey.
Its last annual general meeting (AGM) was held on 25 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop A – 1 Saileela Tower Vinay Complex Nile Gaon, Mumbai, Maharashtra, India – 401203.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.05 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹11,690 (net margin 0.2%) and EBITDA of ₹90,565 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 16% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Allegiant Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0020251). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2017PTC291235
Registration Number 291235
Incorporation Date 15 February 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0020251
Recognitions & Rankings of Allegiant Pharma
Contact details
Allegiant Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop A – 1 Saileela Tower Vinay Complex Nile Gaon, Mumbai, Maharashtra, India – 401203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Allegiant Pharma Private Limited, buy the company report.
Comprehensive company report
Allegiant Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Allegiant Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Allegiant Pharma Private Limited, buy the company report.
Financials of Allegiant Pharma Private Limited
FY 2024 filings availableAllegiant Pharma Private Limited reported revenue of ₹47.05 Lakh (up 48% YoY) for FY 2024.
Revenue · FY 2024
₹47.05 Lakh ▲ 48%
Net profit · FY 2024
₹11,690 margin 0.2%
EBITDA · FY 2024
₹90,565 margin 1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 20%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 20%
5 years · compounded
▲ 27%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 48% growth in the latest year. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90,565 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,690 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Allegiant Pharma Private Limited, buy the company report.
Board of directors of Allegiant Pharma Private Limited
Allegiant Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Dubey | Director | 15 Feb 2017 | 9 Years 8 Months | Current |
| Rani Devi Ajay Dubey | Director | 10 Sep 2024 | 2 Years 1 Months | Current |
Auditor
Allegiant Pharma Private Limited is audited by DHIRAJ N SINGH AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHIRAJ N SINGH AND ASSOCIATES | FY 2023 | 156218 |
Shareholding
The shareholding of Allegiant Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Allegiant Pharma Private Limited, buy the company report.
Legal cases
Allegiant Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by M/S Indiana Healthcare Through Proprietor Mr Chetan Jain | Pending |
To see the full case history of Allegiant Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Allegiant Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Allegiant Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA2441P1Z7 | Maharashtra | Active | 27 Jul 2017 |
To see the full GST registrations and return filing status of Allegiant Pharma Private Limited, buy the company report.
Recent activity
Allegiant Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Pankaj Omprakash Tiwari ceased to be Director on 10 Sep 2024.
AGM
Allegiant Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.
Ceased
Pankaj Omprakash Tiwari ceased to be Director.
Appointed
Rani Devi Ajay Dubey was appointed as Director.
Filing
Allegiant Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Ajay Kumar Dubey was appointed as Director.
Incorporation
15 Feb 2017
Allegiant Pharma Private Limited was registered on 15 Feb 2017 with Roc Mumbai & aged 9 years 8 months as per MCA records.
Frequently asked questions
Allegiant Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 February 2017 (9+ years old) and is registered under CIN U74999MH2017PTC291235.
Allegiant Pharma has 2 current directors:
- Ajay Kumar Dubey - Director
- Rani Devi Ajay Dubey - Director
The latest financial statements of Allegiant Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 25 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Allegiant Pharma is 27AAPCA2441P1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Allegiant Pharma is U74999MH2017PTC291235. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allegiant Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Allegiant Pharma was incorporated on 15 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Pankaj Omprakash Tiwari ceased to be Director on 10 Sep 2024. Rani Devi Ajay Dubey was appointed as Director on 10 Sep 2024. Ajay Kumar Dubey was appointed as Director on 15 Feb 2017.
Yes, Allegiant Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0020251).
The registered office of Allegiant Pharma is at Shop A – 1 Saileela Tower Vinay Complex Nile Gaon, Mumbai, Maharashtra, India – 401203.